Virtus LifeSci Biotech Products ETF
11 hedge funds and large institutions have $1.94M invested in Virtus LifeSci Biotech Products ETF in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less capital invested
Capital invested by funds: $6.14M → $1.94M (-$4.2M)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$32.2K | |
| 3 | +$19.5K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$7.5K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.39M | |
| 3 | -$498K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$219K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18.9K |